Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» prostate cancer
prostate cancer
Can Valeant transform Dendreon's ailing Provenge into a viable cancer competitor?
Fierce Pharma Marketing
Wed, 02/11/15 - 12:04 pm
Valeant Pharmaceuticals
Dendreon
Provenge
prostate cancer
OncoGenex to Regain Rights to Custirsen from Teva
Yahoo
Tue, 12/30/14 - 10:27 am
OncoGenex
Teva Pharmaceutical
custirsen
lung cancer
prostate cancer
Aeterna Zentaris: Final Data for Phase 1 Portion of Ongoing Phase 1/2 Trial with Zoptarelin Doxorubicin in Prostate Cancer Published in Clinical Cancer Research
Yahoo
Mon, 12/29/14 - 09:34 am
Aeterna Zentaris
prostate cancer
zoptarelin doxorubicin
Dendreon's Alternate Reality
Motley Fool
Thu, 12/4/14 - 10:40 am
Dendreon
BFG Pharma
M&A
Provenge
prostate cancer
Exelixis drops 15% after prostate cancer drug candidate fails Phase 3
Seeking Alpha
Mon, 12/1/14 - 11:31 am
Exelixis
prostate cancer
cabozantinib
Isis/AstraZeneca Expand Antisense Technology Collaboration
Yahoo/Zacks
Sat, 11/15/14 - 09:30 am
AstraZeneca
Isis Pharmaceuticals
antisense
ISIS-STAT3Rx
hepatocellular carcinoma
prostate cancer
ISIS-ARRx
Should Johnson & Johnson Buy Medivation Inc.?
Motley Fool
Wed, 11/12/14 - 08:41 am
JNJ
Medivation
M&A
Xtandi
prostate cancer
Strong Prostate Cancer Drug Sales Will Help Medivation Expand Pipeline
TheStreet.com
Wed, 11/5/14 - 08:07 am
prostate cancer
Medivation
Xtandi
Billionaire Carl Berg developing prostate cancer test
San Francisco Chronicle,
Sun, 11/2/14 - 09:29 am
prostate cancer
diagnostics
Carl Berg
Berg LLC
Myriad Gets Reimbursement OK On Prostate Cancer Test
Investors.com
Fri, 10/17/14 - 07:02 pm
Myriad Genetics
prostate cancer
diagnostics
Medicare
J&J Likely To Report Drop In Zytiga Sales On Xtandi‘s Entry In Prostate Cancer Market
Bidness Etc.
Mon, 09/22/14 - 09:56 am
Zytiga
Xtandi
JNJ
prostate cancer
Medivation
Astellas
OncoGenex's Phase III Prostate Cancer Study Fully Enrolled
Yahoo/Zacks.com
Fri, 09/19/14 - 08:51 am
OncoGenex
prostate cancer
Jevtana
U.S. FDA okays expanded use of Medivation prostate cancer drug
Yahoo/Reuters
Wed, 09/10/14 - 08:35 pm
Medivation
FDA
prostate cancer
Xtandi
Exelixis Drug Fails Pivotal Prostate Cancer Study; Laying Off 70% of Employees
TheStreet.com
Tue, 09/2/14 - 07:54 am
Exelixis
prostate cancer
cabozantinib
layoffs
Advaxis, Merck to test immune therapies against prostate cancer
Yahoo/Reuters
Mon, 08/25/14 - 08:19 am
Advaxis
Merck
prostate cancer
immuno-oncology
ADXS: What Does the J&J Deal with Aduro Mean for Advaxis?
Yahoo/Zacks.com
Mon, 06/2/14 - 11:04 am
JNJ
Aduro BioTech
Advaxis
Janssen Biotech
prostate cancer
ASCO
New England Journal of Medicine Publishes Results From Phase 3 PREVAIL Trial Of Enzalutamide In Men With Chemotherapy-Naïve Metastatic Prostate Cancer
Yahoo/BusinessWire
Sun, 06/1/14 - 11:40 am
Enzalutamide
prostate cancer
metastatic prostate cancer
Xtandi
Astellas
Johnson & Johnson Collaborates with Aduro BioTech
Yahoo/Zacks.com
Fri, 05/30/14 - 12:22 pm
JNJ
Aduro BioTech
prostate cancer
Novogen Identifies Highly Active Drug Candidates Against Prostate Cancer
Yahoo
Tue, 05/27/14 - 09:19 am
prostate cancer
Novogen
Myriad Genetics Unveils Positive Prolaris Data
Yahoo/Zacks.com
Wed, 05/21/14 - 04:13 pm
Myriad Genetics
Prolaris
prostate cancer
Pages
« first
‹ previous
…
8
9
10
11
12
13
14
15
16
…
next ›
last »